Search results
Results from the WOW.Com Content Network
She is also editor-in-chief, Molecular Cancer Research [2] Dr. Knudsen currently holds leadership roles with some of the most important cancer entities in the nation. She serves on the board of advisors for the National Cancer Institute and on 12 external advisory boards for NCI-designated cancer centers.
Licinio is the founding and current chief editor of three journals from Springer Nature, Molecular Psychiatry, [5] Translational Psychiatry, [6] and Discover Mental Health. [ 7 ] His area of scientific expertise is precision medicine with a focus on pharmacogenomics , [ 8 ] as well as the biology of depression , and he has edited books on both ...
New York State Electric and Gas (NYSEG) is an electric and gas utility company owned by Avangrid that serves customers in New York. NYSEG was incorporated in 1852 as ...
Molecular Cancer is a peer-reviewed open-access scientific journal covering all aspects of cancer research. The journal is published by BioMed Central and was established in 2002. The first editor-in-chief was Chi V. Dang, who is also the scientific director of the Ludwig Institute for Cancer Research . [ 1 ]
Molecular Cancer Research is a monthly peer reviewed academic journal published by the American Association for Cancer Research. Prior to September 2002 it was known as Cell Growth & Differentiation .
In 2013 Feinstein began giving an annual award named after Cerami through the journal; the winner receives $20,000 and the offer to publish an autobiographical piece about their research and what drives it in the journal. [6] As of 2014, the editor-in-chief is Betty Diamond. Molecular Medicine is indexed by PubMed and the Web of Science.
The Feinstein Institutes for Medical Research in Manhasset, New York, United States, on Long Island, is the research home of Northwell Health. [2] Feinstein Institutes is home to 50 research labs, 2,500 clinical research studies, and 5,000 professional and support staff.
Li-Kuo Su became Editor-in-Chief in 2003 and is recognized for promoting the journal's growth and establishing it as one of the most reputable cancer research journals. He retired from his editorial activities in 2019. Steve Mao became Cancer Cell 's Editor-in-Chief in 2020 after serving as senior editor at Cell and Science.